Medical Oncologist
Metastatic breast cancer
Lapatinib and tucatinib: HER2 tablets and brain metastases
HER2-positive breast cancer can spread to the brain, where large antibody drugs reach less easily. HER2 tablets such as lapatinib and tucatinib are small molecules that enter brain tissue more readily. This page explains, in general terms, how they are used alongside radiation and surgery.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
On this page
- Why are HER2 tablets used when cancer reaches the brain?
- Lapatinib and tucatinib, in general terms
- Treatments used for brain metastases
- What a course usually involves
- The vocabulary, in plain language
- Honest expectations
- Symptoms that can point to brain involvement
- Daily life during treatment for brain metastases
- How families can help after a brain metastasis diagnosis
- What people assume about brain metastases
- Common questions about HER2 tablets and brain metastases
The short answer
Why are HER2 tablets used when cancer reaches the brain?
HER2-positive breast cancer spreads to the brain more often than some other types. Antibody drugs such as trastuzumab are large molecules that do not pass easily into the brain. HER2 tablets such as lapatinib and tucatinib are small molecules that can reach brain tissue more readily. Tucatinib, combined with trastuzumab and capecitabine, has been shown to help women with HER2-positive metastatic breast cancer, including those with brain metastases, live longer.
Where tablets fit alongside other treatment
Brain metastases are often treated first with focused radiation or, sometimes, surgery. HER2 tablets can then help control disease in the brain and the rest of the body together.
Lapatinib and tucatinib compared
Lapatinib was the first HER2 tablet and has been used for many years. Tucatinib is newer and more selective for HER2, which tends to mean fewer skin side effects, though loose motions remain common with both.
Who these tablets may not suit
People with significant liver problems, those unable to take tablets reliably, and situations where other treatments are more appropriate. Availability and cost in India also vary.
This page gives general information only. Treatment choices for brain metastases are made by your oncology team.Side by side
Lapatinib and tucatinib, in general terms
Lapatinib
Tucatinib
Older, longer experience
Newer, more selective for HER2
Often combined with capecitabine
Combined with trastuzumab and capecitabine
Loose motions and rash common
Loose motions common, rash less so
Some activity in the brain
Studied specifically including brain metastases
More widely available
Availability and cost vary
The options
Treatments used for brain metastases
Most women receive a combination, chosen according to the number, size and position of the metastases.
Focused radiation
High doses aimed precisely at one or a few metastases, sparing surrounding brain. Often given in a single or a few sessions.
Whole-brain radiation
Used when there are many metastases. It can affect memory and thinking, so it is used more selectively than in the past.
Ask about memory-protecting approaches.Surgery
Sometimes used to remove a single large metastasis causing pressure or symptoms, usually followed by radiation.
HER2-targeted drugs
Tablets such as tucatinib or lapatinib, and newer antibody-drug treatments, help control disease in the brain and body.
Also important
- Steroids to reduce brain swelling
- Medicines to prevent seizures if needed
- Rehabilitation and symptom care
Taking the tablets
What a course usually involves
Blood tests before starting
Liver tests and blood counts are checked, since these drugs can affect both.
Taking tablets at set times
Tucatinib is taken twice a day, alongside capecitabine tablets and trastuzumab given by drip or injection.
Managing loose motions early
Your team will advise on anti-diarrhoea medicine and when to call.
Regular brain scans
MRI scans every few months check how brain metastases are responding.
Adjusting when needed
Doses are often lowered to manage side effects, helping people stay on treatment.
Words you will hear
The vocabulary, in plain language
- Brain metastases
- Breast cancer that has spread to the brain.
- Blood-brain barrier
- A natural filter that stops many drugs entering brain tissue.
- Tyrosine kinase inhibitor
- A small molecule drug that blocks growth signals inside cells.
- Stereotactic radiosurgery
- Highly focused radiation aimed at small targets in the brain.
- Leptomeningeal disease
- Cancer spreading to the lining of the brain and spinal cord, which is treated differently.
- MRI
- A detailed scan used to find and monitor brain metastases.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Being straight with you
Honest expectations
Brain metastases are a serious development, and hearing this news is very hard. Treatment has improved considerably, though. Many women with HER2-positive disease now live longer with brain metastases than was possible in the past, and many maintain a good quality of life.
Results vary widely
How well treatment works depends on the number and size of metastases, how the rest of the cancer is behaving, and your overall health.
Side effects need attention
Loose motions from HER2 tablets and effects of radiation on energy and thinking can affect daily life. Report symptoms early so they can be managed.
Access can be a barrier
Newer drugs may be expensive or not widely available. Ask your team what options are realistic for you and whether support or trials exist.
What this page cannot tell you
It cannot tell you how your own cancer will respond. Ask your oncologist what each treatment aims to achieve.
Knowing the signs
Symptoms that can point to brain involvement
Brain metastases do not always cause symptoms, but some signs should always be reported promptly to your team.
Headaches that are new or different
Especially headaches that are worse in the morning, come with vomiting, or steadily worsen over days.
Changes in movement or senses
Weakness or numbness on one side, trouble with balance, blurred or double vision, or difficulty finding words.
Changes in behaviour or thinking
Confusion, memory problems or personality changes noticed by family members. A seizure always needs urgent medical attention.
Living with it
Daily life during treatment for brain metastases
Treatment for brain metastases can affect independence as well as health. Planning ahead helps families cope.
Driving
Most people are advised not to drive for a period after a brain metastasis diagnosis or a seizure. Ask your team when it may be safe.
Steroids
Steroids reduce swelling but can raise blood sugar, increase appetite and disturb sleep. Take them as prescribed and do not stop suddenly.
Support at home
Tiredness, thinking changes or weakness may mean extra help is needed. Occupational therapists and palliative care teams can advise on practical support.
For families
How families can help after a brain metastasis diagnosis
A diagnosis of brain metastases affects the whole family. Loved ones often notice changes before the person themselves does, and practical help at home can make treatment much easier to manage.
Watching for changes
Family members can keep a simple note of new headaches, confusion, weakness, changes in speech or behaviour, and any seizure, then share it with the team. Clear observations help doctors decide quickly whether a scan or a change in treatment is needed.
Helping with tablets and appointments
With several tablets at different times, plus steroids and seizure medicines for some, a written chart or pill organiser helps avoid missed or doubled doses. Someone accompanying appointments can also help remember what was said.
Looking after yourselves
Caring for someone with brain metastases is demanding. Ask the team about counselling, palliative care support and caregiver groups, and share tasks so no one person carries everything.
Commonly believed
What people assume about brain metastases
Spread to the brain means nothing more can be done.
Radiation, surgery and HER2-targeted drugs can control brain metastases, often for a long time. Many women continue active treatment and live meaningful lives.
Chemotherapy cannot reach the brain at all.
Many large drugs are kept out, but some small molecule tablets, including tucatinib and lapatinib, reach brain tissue more easily.
Whole-brain radiation is always needed.
Focused radiation is often used instead when there are only a few metastases, sparing more of the healthy brain.
If steroids help, I can keep taking them long-term.
Steroids have significant long-term side effects. Your team aims to use the lowest dose for the shortest time.
Questions we are asked
Common questions about HER2 tablets and brain metastases
Is tucatinib available in India?
Availability changes over time and may be limited or costly. Ask your oncology team what is currently available, and about alternatives such as lapatinib or trials.
Do I still need radiation if I take tablets?
Often yes. Radiation or surgery is usually used for brain metastases, with drug treatment helping control disease in the brain and body afterwards.
How are loose motions managed?
With anti-diarrhoea medicine, fluids and dose adjustments when needed. Call your team if loose motions continue despite medicine.
How often will I have brain scans?
Usually every few months, or sooner if new symptoms appear. Your team sets the schedule.
Can I travel during treatment?
Discuss it with your team first, especially if you have had a seizure or take steroids.
Will radiation affect my memory?
Whole-brain radiation can affect memory and thinking. Focused radiation has less effect. Ask your team about ways to protect memory.
Should I ask about clinical trials?
Yes. Trials for HER2-positive brain metastases can offer access to newer treatments. Ask whether any are open to you.
Where can I read about my own drugs?
Your oncology team will give you written information about each drug in your plan. Use that as your main reference.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- New England Journal of Medicine — Tucatinib, trastuzumab and capecitabine for HER2-positive metastatic breast cancer (HER2CLIMB)
- Cancer Research UK — Lapatinib (Tyverb)
- Breast Cancer Now — Secondary breast cancer in the brain
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.